CVS currently has a dividend yield of 2.8% and shares have climbed by over 13% in the past year. The good news is, if investors had any concerns about the future of CVS closing out Q4, the company's latest earnings statement should put those worries to rest.CVS currently has a dividend yield of 2.8% and shares have climbed by over 13% in the past year. Given CVS's recent and continued successes on a quarterly and year-over-year basis, 2020 could be one of the best the company has seen yet.Here's an update on Q4 and the investor outlook for the year ahead.The Health Care Benefits segment also experienced restructuring at the start of last year when it took over CVS's SilverScript Medicare Part D plan from Pharmacy Services. SOURCES: Alyssa Dweck, MD, OB/GYN in Westchester, N.Y.; co-author, V is for Vagina. By putting the supplement on its shelves, the drugstore chain is making it more accessible and legitimizing it for a wider market.CVS earnings call for the period ending December 31, 2019.The health-care company runs two business units: retail pharmacy and pharmacy benefit management.CVS earnings call for the period ending December 31, 2018.Could this drug couponing start-up be headed for IPO or is it a takeover target? Either way, it's helping consumers save billions at the pharmacy.The company is adding the product into a handful of stores.They're cheap and pay dividends.Mounting coronavirus worries combined with the Fed's rate cut caused the healthcare giant's shares to tumble.Even the retail pharmacy giant couldn't escape another day of carnage on Wall Street.CVS earnings call for the period ending September 30, 2018.Despite some tailwinds from COVID-19, the drugstore chain doesn't expect earnings growth this year.CVS earnings call for the period ending March 31, 2019.CVS earnings call for the period ending March 31, 2020.One company is tightening its rules on certain products, and the other is adding its product to a handful of stores.These brand-name companies are big-time bargains for patient investors.All three retail pharmacy giants take a step back after Walgreens withdraws its full-year outlook.The effort follows a clutch of unsuccessful attempts both in Congress and with the court.CVS earnings call for the period ending September 30, 2019.3 quality companies to build your stock portfolio responsibly.CVS earnings call for the period ending September 30, 2017.The healthcare giant's third-quarter earnings report gave investors reasons to cheer.These companies could see their sales soar as seniors increasingly choose to live in their homes longer.You don't need a mountain of cash to generate significant wealth from the stock market.Over the past 11 years, CVS Health has posted a solid return, but was it the best option?These companies have low P/E ratios and high dividend yields and investors stand to profit from that combination.A strong earnings report and interest from an activist investor helped lift the stock.CVS earnings call for the period ending June 30, 2018.CVS earnings call for the period ending March 31, 2018.CVS earnings call for the period ending June 30, 2019.The insurer was the key source of the combined businesses' higher third-quarter profits.Investors are excited about a potential huge federal stimulus package.The stock market is crashing due to coronavirus worries, and the healthcare giant is getting caught in the undertow.Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.Here's why a telemedicine company that offers birth control pill deliveries is rapidly gaining traction.Several health insurance stocks took a step back on Monday following Nevada's caucus results.Better-than-expected Q2 results are making investors happy.